Literature DB >> 3543131

Identification of specific and cross-reactive antigens of Leishmania donovani chagasi by human infection sera.

S G Reed, R Badaro, R M Lloyd.   

Abstract

Cloned Leishmania donovani chagasi (Ldc) promastigotes were analyzed by SDS-PAGE separation and immunoblotting with human infection sera. The patterns of antigen reactivity were compared by using sera from individuals with Ldc, Leishmania mexicana amazonensis (Lma), Trypanosoma cruzi, Mycobacterium tuberculosis, or Mycobacterium leprae infections. Sera from individuals with these infections recognized Ldc antigens in several m.w. ranges. Reactivity was due to recognition of Ldc molecules and not to Ldc culture medium components, as shown by comparing Ldc promastigotes grown in the presence or absence of fetal bovine serum (FBS), by immunoblotting of FBS, and by [35S]methionine labeling. The major findings of the study were as follows. Immunoblots with Ldc promastigotes could be used to distinguish individuals with Ldc infections from those with Lma infections. Persons with Ldc infections had antibodies to a Ldc antigen of approximately 32 to 35 kd not recognized by persons with Lma infections. Individuals cured of acute Ldc infection did not develop antibodies that differed in specificity to those present during their acute phase of infection. Ldc antigens in the 62 to 66 kd region were recognized by all individuals with Ldc or Lma infections but were not recognized by individuals in the other disease groups or by control sera. This region was found to contain at least four distinct bands, one of which appeared to be glycosylated as indicated by periodic acid-Schiff staining and concanavalin A labeling; an apparently nonglycosylated protein of 62 to 63 kd was eluted from SDS-PAGE gels and was used to diagnose Ldc infection by the ELISA. Whereas crude Ldc antigen gave false positive results with T. cruzi and mycobacteria infection sera, the eluted 62 to 63 kd protein was 100% specific and sensitive in the diagnosis of Ldc infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3543131

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  In vitro responses to Leishmania antigens by lymphocytes from patients with leishmaniasis or Chagas' disease.

Authors:  S G Reed; E M Carvalho; C H Sherbert; D P Sampaio; D M Russo; O Bacelar; D L Pihl; J M Scott; A Barral; K H Grabstein
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

2.  Immunoenzymatic assay for the diagnosis of American tegumentary leishmaniasis using soluble and membrane-enriched fractions from infectious Leishmania (Viannia) braziliensis.

Authors:  Jamyra Iglesias Cataldo; Fernanda Carvalho de Queiroz Mello; Eliame Mouta-Confort; Maria de Fátima Madeira; Armando de Oliveira Schubach; Marcelo da Silva Genestra; Flávia Coelho Ribeiro; Célia de Fátima Moreira-Venâncio; Sônia Regina Lambert Passos
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  Identification of potentially diagnostic Leishmania braziliensis antigens in human cutaneous leishmaniasis by immunoblot analysis.

Authors:  M E Brito; M G Mendonça; Y M Gomes; M L Jardim; F G Abath
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

4.  Cloning, characterization, and serodiagnostic evaluation of Leishmania infantum tandem repeat proteins.

Authors:  Yasuyuki Goto; Rhea N Coler; Jeffrey Guderian; Raodoh Mohamath; Steven G Reed
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

5.  Leishmania major-like antigen for specific and sensitive serodiagnosis of human and canine visceral leishmaniasis.

Authors:  Rosângela Barbosa-De-Deus; Marcos Luíz Dos Mares-Guia; Adriane Zacarias Nunes; Kátia Morais Costa; Roberto Gonçalves Junqueira; Wilson Mayrink; Odair Genaro; Carlos Alberto Pereira Tavares
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

6.  Serodiagnosis of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica in Sanliurfa Province, Turkey, where ACL Is highly endemic.

Authors:  Fadile Yildiz Zeyrek; Metin Korkmaz; Yusuf Ozbel
Journal:  Clin Vaccine Immunol       Date:  2007-08-29

7.  The efficacy of L. (L.) chagasi excreted-secreted antigens (ESAs) for visceral leishmaniasis diagnosis is due to low levels of cross-reactivity.

Authors:  Viviana Pinedo-Cancino; Norival Kesper; Clara Lúcia Barbiéri; José Angelo Lauletta Lindoso; Eufrosina Setsu Umezawa
Journal:  Am J Trop Med Hyg       Date:  2013-01-16       Impact factor: 2.345

8.  Immunoblot analysis of the humoral immune response to Leishmania donovani polypeptides in cases of human visceral leishmaniasis: its usefulness in prognosis.

Authors:  Promod Kumar; Kalpana Pai; Kiran Tripathi; H P Pandey; Shyam Sundar
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

9.  Immunoblotting identifies an antigen recognized by anti gp63 in the immune complexes of Indian kala-azar patient sera.

Authors:  T Sanyal; D K Ghosh; D Sarkar
Journal:  Mol Cell Biochem       Date:  1994-01-12       Impact factor: 3.396

10.  Evaluation of cleaving agents other than trypsin in direct agglutination test for further improving diagnosis of visceral leishmaniasis.

Authors:  A el Harith; S Chowdhury; A al-Masum; S Semião-Santos; E Karim; S el-Safi; I Haque
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.